H19 is reported to be associated with some types of carcinoma, and it is overexpressed and acts as an oncogene in breast [19, 20], bladder [23], glioma [32], and prostate [33] cancers; however, it still functions as a tumor-suppressor in hepatocellular cancer [34]. This evidence concerns the gene H19 and carcinoma.